Bruno Vincenzi
Università Campus Bio-Medico · 953 works · 21,171 citations · h-index 72
Top works
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
- Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.
- Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.
- High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
- 1560O Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection
- Zoledronic Acid-Related Angiogenesis Modifications and Survival in Advanced Breast Cancer Patients
- Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors
- Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
- Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
- Fever After Zoledronic Acid Administration Is Due to Increase in TNF- α and IL-6
- Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib
- The antineoplastic role of bisphosphonates: from basic research to clinical evidence
- Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
- Idiosyncratic reaction after oxaliplatin infusion
- Repeated Intermittent Low-Dose Therapy with Zoledronic Acid Induces an Early, Sustained, and Long-Lasting Decrease of Peripheral Vascular Endothelial Growth Factor Levels in Cancer Patients
- Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB–IIA non-small cell lung cancer
- Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network
- Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer
- Mesenchymal chondrosarcoma: Prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study